Ranibizumab in neovascular age-related macular degeneration: a 5-year follow-up

URN to cite this document:: urn:nbn:de:bvb:355-epub-339350
DOI to cite this document:: 10.5283/epub.33935

Cvetkova, Nadezhda ; Hölldobler, Kristina ; Prahs, Philipp ; Radeck, Viola ; Helbig, Horst ; Märker, David

Preview

PDF
(401kB)

Date of publication of this fulltext: 24 Jun 2016 12:28

Alternative links to fulltext:DOI Publisher

Details

Preview

Export bibliographical data

Abstract

Purpose: Our aim was to evaluate an optical coherence tomography (OCT) and visual acuity (VA)-guided, variable-dosing regimen with intravitreal ranibizumab injection for treating patients with neovascular age-related macular degeneration (AMD) from 2007 to 2012. Design: This was a retrospective clinical study of 5 years follow-up in a tertiary eye center. Patients and methods: In this study, ...